For Research Use Only
CJC-1295 / Ipamorelin 10mg Pen is supplied exclusively for in vitro laboratory research. Not for human or veterinary administration. Not an injection device for clinical or personal use.
CJC-1295 / Ipamorelin 10mg Pen — Research Peptide Dispensing Format
The CJC-1295 / Ipamorelin 10mg Pen is a pen-format research preparation containing 5mg CJC-1295 No DAC (Modified GRF 1-29, GHRHR agonist) and 5mg Ipamorelin (GHSR-1a agonist), supplied as a pre-loaded cartridge for use with the AbsoluteBioLab Reusable Metal Peptide Pen v3 dispensing device. The compound chemistry, analytical specification, and research context are documented on the canonical CJC-1295 No DAC + Ipamorelin 10mg vial product page. Batch-specific analytical documentation is available through the AbsoluteBioLab CoA Portal.
Format Specification
| Attribute | Specification | Notes |
|---|---|---|
| Format | Pen cartridge — research dispensing format | Pre-loaded cartridge for use with Reusable Metal Peptide Pen v3 |
| Component 1 | CJC-1295 No DAC 5mg (Modified GRF 1-29) | GHRHR agonist; compound-level CoA available |
| Component 2 | Ipamorelin 5mg | GHSR-1a agonist; compound-level CoA available |
| Purity (RP-HPLC) | ≥99.0% each component | Compound-level CoA; verify against batch documentation |
| Identity (ESI-MS) | Both components confirmed | Compound-level CoA; verify against batch documentation |
| Compatible Device | Reusable Metal Peptide Pen v3 | Device page |
| Intended Use | Laboratory research dispensing | Research use only; not for human or veterinary administration |
Research Context
CJC-1295 No DAC (Modified GRF 1-29) is a GHRH analogue that acts at the GHRH receptor (GHRHR). Ipamorelin is a selective GHSR-1a agonist. Both compounds have been studied in the context of GH secretagogue research. For the full research context, analytical specification, and scientific references, refer to the canonical CJC-1295 No DAC + Ipamorelin 10mg vial product page. For a comparison of CJC-1295 with and without DAC, refer to the CJC-1295 DAC vs No DAC Research Comparison.
Batch Documentation
Compound-level CoA documentation is available via the AbsoluteBioLab CoA Portal.
Frequently Asked Questions
What is the difference between the CJC-1295 / Ipamorelin Pen and the vial?
The CJC-1295 No DAC + Ipamorelin 10mg vial contains the co-lyophilised blend in a standard vial format. The pen contains the same blend in a pre-loaded pen cartridge format for use with the Reusable Metal Peptide Pen v3 dispensing device. The compound chemistry and analytical specification are the same for both formats.
What is CJC-1295 No DAC?
CJC-1295 No DAC (Modified GRF 1-29) is a GHRH analogue corresponding to the first 29 amino acids of GHRH with four amino acid substitutions that improve stability. It does not contain the Drug Affinity Complex (DAC) modification present in CJC-1295 with DAC. Refer to the CJC-1295 DAC vs No DAC Research Comparison for further information.
Reviews
There are no reviews yet.